DIMINI - Diabetes Mellitus? - Not me!

NCT ID: NCT03482674

Last Updated: 2018-04-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

530 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-01-02

Study Completion Date

2020-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The increasing prevalence of type 2 diabetes mellitus is a worldwide problem. In preventing risk factors and unhealthy lifestyle through improved health literacy, chances are seen to delay or even avoid type 2 diabetes mellitus. The aim of the DIMINI-project is to prevent type 2 diabetes mellitus and to strengthen the health literacy of people at increased risk of developing it. For this purpose, people at increased risk are first identified by using the standardized screening tool Finnish Diabetes Risk Score (FINDRISC) adapted for Germany. Identified risk persons then receive a needs-based, modular lifestyle intervention including nutrition tips and physical exercises either paper- or app-based.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

DIMINI, a randomised controlled trial, will assess whether the implementation of a lifestyle intervention for people at increased risk of developing type 2 diabetes mellitus will result in an improvement in body weight (primary outcome) and participants health literacy (secondary outcome) or not. A three-month intervention in the intervention group is followed by a one-year follow-up. The control group receives standard care as provided by the German statutory health insurance for three months and a one-year follow-up as well.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Health Behavior Health Knowledge, Attitudes, Practice Literacy Diabetes Mellitus, Type 2 Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Group

The control group will receive standard care as provided by the German statutory health insurance.

Group Type NO_INTERVENTION

No interventions assigned to this group

Intervention group

The intervention group receives the DIMINI lifestyle intervention for a period of three months.

Group Type EXPERIMENTAL

DIMINI lifestyle intervention

Intervention Type BEHAVIORAL

DIMINI lifestyle intervention consists of the DIMINI-kit which contains health information, a list of food recommendations with additional information on calories, serving size and weight (traffic light rating system), a nutrition and an exercise diary. Participants in the intervention group can choose between a paper-based version or an app-based version of the DIMINI-kit. In addition, the kit includes an elastic exercise band with exercise poster, a measuring tape for self-control of the waist size and a pedometer.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

DIMINI lifestyle intervention

DIMINI lifestyle intervention consists of the DIMINI-kit which contains health information, a list of food recommendations with additional information on calories, serving size and weight (traffic light rating system), a nutrition and an exercise diary. Participants in the intervention group can choose between a paper-based version or an app-based version of the DIMINI-kit. In addition, the kit includes an elastic exercise band with exercise poster, a measuring tape for self-control of the waist size and a pedometer.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age ≥ 18 years
* resident in Hesse or Schleswig-Holstein
* statutory health insurance in one out of five participating health insurances
* overweight/obesity
* low physical activity
* known family disposition for type 2 diabetes mellitus
* history of increased glucose levels
* FINDRISC results with scores ≥ 12

Exclusion Criteria

* age \< 18 years
* resident outside Hesse or Schleswig-Holstein
* statutory or private health insurance with other than the participating health insurances
* clinically manifested diabetes mellitus
* malnutrition
* psychiatric disorders
* pregnancy
* FINDRISC results with scores \<12
* participation in other clinical trials
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Deutsche Diabetes Gesellschaft

OTHER

Sponsor Role collaborator

Dimini Konsortium

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Carsten Petersen, Dr.

Role: PRINCIPAL_INVESTIGATOR

docevent GmbH

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

docevent GmbH

Schleswig, Schleswig-Holstein, Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Carsten Petersen, Dr.

Role: CONTACT

+494621-855 425

Volker E Amelung, Prof. Dr.

Role: CONTACT

+4930-24631222

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Carsten Petersen, Dr.

Role: primary

+494621-855 425

References

Explore related publications, articles, or registry entries linked to this study.

Puschner F, Wetzel S, Urbanski-Rini D, Bertram N, Schliffke M, Gohl M, Petersen C; Dimini Consortium. The association between the risk of developing type 2 diabetes mellitus and health-related quality of life: baseline results from the Dimini lifestyle intervention. Qual Life Res. 2021 Dec;30(12):3523-3533. doi: 10.1007/s11136-021-02878-2. Epub 2021 May 19.

Reference Type DERIVED
PMID: 34008163 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

01NVF17012

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Diabetes Knowledge Assessment
NCT00198900 COMPLETED
Michigan Men's Diabetes Project
NCT04760444 COMPLETED NA